Advanced search
Publication Cover
OncoTargets and Therapy Volume 12, 2019 - Issue
Submit an article Journal homepage
36
Views
14
CrossRef citations to date
0
Altmetric
Original Research

CLK3 Is A Direct Target Of miR-144 And Contributes To Aggressive Progression In Hepatocellular Carcinoma

Hua Li1 Department of Infectious Diseases, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, People’s Republic of China
,
Xichun Cui2 Key Laboratory of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, People’s Republic of China
,
Qiuyue Hu2 Key Laboratory of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, People’s Republic of China
,
Xiaolong Chen2 Key Laboratory of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, People’s Republic of China
&
Pengli Zhou3 Department of Intervention, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450014, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-3145-0082
ORCID Icon
Pages 9201-9213 | Published online: 05 Nov 2019

References

  • Siegel RL, Miller KD, Dvm AJ. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):11. doi:10.3322/caac.21442
  • Ayuso C, Rimola J, Vilana R, et al. Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines. Eur J Radiol. 2018;101:72. doi:10.1016/j.ejrad.2018.01.02529571804
  • Bullock AN, Das S, Debreczeni JE, et al. Kinase domain insertions define distinct roles of CLK kinases in sr protein phosphorylation. Structure. 2009;17(3):352–362. doi:10.1016/j.str.2008.12.02319278650
  • Becker W, Kentrup H, Heukelbach J, Joost HG. cDNA cloning and characterization of rat Clk3, a LAMMER kinase predominately expressed in testis. Biochim Biophys Acta. 1996;1312(1):63–67. doi:10.1016/0167-4889(96)00036-58679717
  • Cesana M, Guo MH, Cacchiarelli D, et al. A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development. Cell Stem Cell. 2018;22(4):575. doi:10.1016/j.stem.2018.03.01229625070
  • Garzon R, Fabbri M, Cimmino A, Calin GA, Croce CM. MicroRNA expression and function in cancer. Trends Mol Med. 2006;12(12):580–587. doi:10.1016/j.molmed.2006.10.00617071139
  • Gregory RI, Shiekhattar R. MicroRNA biogenesis and cancer. Cancer Res. 2011;65(9):3509–3512. doi:10.1158/0008-5472.CAN-05-0298
  • Liang H-W, Ye ZH, Yin SY, et al. A comprehensive insight into the clinicopathologic significance of miR-144-3p in hepatocellular carcinoma. Onco Targets Ther. 2017;10:3405–3419. doi:10.2147/OTT.S13814328744145
  • Bao J, Yu Y, Chen J, et al. MiR-126 negatively regulates PLK-4 to impact the development of hepatocellular carcinoma via ATR/CHEK1 pathway. Cell Death Dis. 2018;9(10):1045. doi:10.1038/s41419-018-1020-030315225
  • Zhang J, He Y, Yu Y, et al. Upregulation of miR‐374a promotes tumor metastasis and progression by downregulating LACTB and predicts unfavorable prognosis in breast cancer. Cancer Med. 2018;7(7):3351–3362. doi:10.1002/cam4.2018.7.issue-7
  • Xue C, He Y, Zhu W, et al. Low expression of LACTB promotes tumor progression and predicts poor prognosis in hepatocellular carcinoma. Am J Transl Res. 2018;10(12):4152–4162.30662658
  • Xue C, He Y, Hu Q, et al. Downregulation of PIM1 regulates glycolysis and suppresses tumor progression in gallbladder cancer. Cancer Manag Res. 2018;10(undefined):5101–5112. doi:10.2147/CMAR.S18438130464610
  • He Y, Xue C, Yu Y, et al. CD44 is overexpressed and correlated with tumor progression in gallbladder cancer. Cancer Manag Res. 2018;10(undefined):3857–3865. doi:10.2147/CMAR.S17568130288117
  • Chen J, Yu Y, Chen X, et al. MiR‐139‐5p is associated with poor prognosis and regulates glycolysis by repressing PKM2 in gallbladder carcinoma. Cell Proliferation. 2018;51(6):e12510.30105813
  • CP B, HS S, GJ G. A network-biology perspective of microRNA function and dysfunction in cancer. Nat Rev Genet. 2016;17(12):719–732. doi:10.1038/nrg.2016.13427795564
  • Tao P, Wen H, Yang B,et al. miR-144 inhibits growth and metastasis of cervical cancer cells by targeting VEGFA and VEGFC. Exp Ther Med. 2018;15(1):562–568.29387205
  • Yin Y, Cai J, Meng F, Sui C, Jiang Y. MiR-144 suppresses proliferation, invasion, and migration of breast cancer cells through inhibiting CEP55. Cancer Biol Ther. 2018;19(4):306–315. doi:10.1080/15384047.2017.141693429561704
  • Cao T, Li H, Hu Y, Ma D, Cai X. miR-144 suppresses the proliferation and metastasis of hepatocellular carcinoma by targeting E2F3. Tumor Biol. 2014;35(11):10759–10764. doi:10.1007/s13277-014-2017-7
  • Sheng S, Xie L, Wu Y, et al. Mir-144 inhibits growth and metastasis in colon cancer by downregulating SMAD4. Bioscience Reports. 2019;39(3).
  • Zhou S, Ye W, Zhang Y, et al. miR-144 reverses chemoresistance of hepatocellular carcinoma cell lines by targeting Nrf2-dependent antioxidant pathway. Am J Transl Res. 2016;8(7):2992.27508019
  • Holland J D, Klaus A, Garratt A N, et al. Wnt signaling in stem and cancer stem cells.[J]. Current Opinion in Cell Biology, 2013, 25(2):254–264.
  • Guo Y, Ying L, Tian Y, et al. miR-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling. FEBS J. 2013;280(18):4531–4538. doi:10.1111/febs.1241723815091
  • Iwaya T, Yokobori T, Nishida N, et al. Downregulation of miR-144 is associated with colorectal cancer progression via activation of mTOR signaling pathway. Carcinogenesis. 2012;33(12):2391–2397. doi:10.1093/carcin/bgs28822983984

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.